MERCURY LABORATORIES
Back to Balance Sheet
|
MERCURY LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹4.18 Cr | ₹4.36 Cr | ₹6.38 Cr | ₹9.64 Cr | ₹9.26 Cr |
What is the latest Total Non-Current Liabilities ratio of MERCURY LABORATORIES ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹4.18 Cr |
Mar2023 | ₹4.36 Cr |
Mar2022 | ₹6.38 Cr |
Mar2021 | ₹9.64 Cr |
Mar2020 | ₹9.26 Cr |
How is Total Non-Current Liabilities of MERCURY LABORATORIES Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹4.18 Cr | -4.18 | |
Mar2023 | ₹4.36 Cr | -31.69 | |
Mar2022 | ₹6.38 Cr | -33.86 | |
Mar2021 | ₹9.64 Cr | 4.18 | |
Mar2020 | ₹9.26 Cr | - |
Compare Total Non-Current Liabilities of peers of MERCURY LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MERCURY LABORATORIES | ₹113.9 Cr | -4% | -2.9% | 21.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹431,844.0 Cr | -1.5% | -5.7% | 52.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹154,155.0 Cr | -2.2% | -6.5% | 68.5% | Stock Analytics | |
CIPLA | ₹123,138.0 Cr | -4.4% | -4.7% | 25.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,391.0 Cr | -3.1% | -5.2% | 18.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,602.3 Cr | -4.5% | -10.6% | 58.1% | Stock Analytics |
MERCURY LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MERCURY LABORATORIES | -4% |
-2.9% |
21.4% |
SENSEX | -1% |
-3.3% |
21.1% |
You may also like the below Video Courses